Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines

被引:1
作者
Qian, Jun-Qiang [1 ]
Sun, Pei [1 ]
Pan, Zhan-Yu [2 ]
Fang, Zhi-Zhong [3 ]
机构
[1] Tianjin Med Univ Canc Inst & Hosp, Dept Pharm, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China
[2] Tianjin Med Univ Canc Inst & Hosp, Dept Integrat Oncol, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China
[3] Tianjin Med Univ, Sch Pharm, Tianjin 300070, Peoples R China
关键词
Annonaceous acetogenins; hepatocellular carcinoma; drug resistance; MULTIDRUG-RESISTANCE; GASTRIC-CANCER; EXPRESSION; PATHWAY; FAMILY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is the most common tumor in worldwide and chemotherapy resistant is a severe obstacle in HCC treatment. Annonaceous acetogenins was a nature compound from Uvaria accuminata and it has show the anti-tumor proliferation activity in many types cancer. In this study, we showed that annonaceous acetogenins is correlated with the drug resistance reversal in human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines. We found that cell apoptosis was improved and cell cycle was arrested, further, multidrug-resistance proteins such as MDR1, MRP1, Topo-II alpha, GST-pi, cyclin D1, Survivin and bcl-2 are down-regulated, however, intracellular Rh-123 and caspase-3/8 was up-regulated by Annonaceous acetogenins treatment. We also found that there was a decreased activity of NF-.B and Akt in Annonaceous acetogenins treatment groups. Therefore, we demonstrate that Akt/NF-kappa B pathway was involved in Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma cells.
引用
收藏
页码:11934 / 11944
页数:11
相关论文
共 28 条
[1]   Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1) [J].
Bakos, Eva ;
Homolya, Laszlo .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2007, 453 (05) :621-641
[2]   NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells [J].
Bentires-Alj, M ;
Barbu, V ;
Fillet, M ;
Chariot, A ;
Relic, B ;
Jacobs, N ;
Gielen, J ;
Merville, MP ;
Bours, V .
ONCOGENE, 2003, 22 (01) :90-97
[3]   FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway [J].
Cheng, L. ;
Luo, S. ;
Jin, C. ;
Ma, H. ;
Zhou, H. ;
Jia, L. .
CELL DEATH & DISEASE, 2013, 4 :e923-e923
[4]   The PI3K Pathway As Drug Target in Human Cancer [J].
Courtney, Kevin D. ;
Corcoran, Ryan B. ;
Engelman, Jeffrey A. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) :1075-1083
[5]   Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy [J].
Czabotar, Peter E. ;
Lessene, Guillaume ;
Strasser, Andreas ;
Adams, Jerry M. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (01) :49-63
[6]   2-acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-κB pathway [J].
Deng, L ;
Lin-Lee, YC ;
Claret, FX ;
Kuo, MT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (01) :413-420
[7]   Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma [J].
Gao, Xu-dong ;
Qu, Jian-hui ;
Chang, Xiu-juan ;
Lu, Yin-ying ;
Bai, Wen-lin ;
Wang, Hong ;
Xu, Zhong-xian ;
An, Lin-jing ;
Wang, Chun-ping ;
Zeng, Zhen ;
Yang, Yong-ping .
LIVER INTERNATIONAL, 2014, 34 (01) :136-146
[8]   The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer [J].
Geng, Ming ;
Wang, Lin ;
Chen, Xin ;
Cao, Ruixue ;
Li, Peifeng .
DIAGNOSTIC PATHOLOGY, 2013, 8
[9]   Survivin as a global target of intrinsic tumor suppression networks [J].
Guha, Minakshi ;
Altieri, Dario C. .
CELL CYCLE, 2009, 8 (17) :2708-2710
[10]   Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line [J].
Hochhauser, D ;
Schnieders, B ;
ErcikanAbali, E ;
Gorlick, R ;
MuiseHelmericks, R ;
Li, WW ;
Fan, JG ;
Banerjee, D ;
Bertino, JR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (18) :1269-1275